We are live on ! Find out more
HHMI

Howard Hughes Medical Institute Portfolio holdings

AUM $416M
1-Year Est. Return 13.82%
This Fund
S&P 500
This Quarter Est. Return
+10.8%
1 Year Est. Return
+13.82%
3 Year Est. Return
+59.34%
5 Year Est. Return
+48.21%
10 Year Est. Return
+227.75%
AUM
$301M
AUM Growth
+$282M
Cap. Flow
+$264M
Cap. Flow %
87.67%
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
Reduced
Closed
1

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$280M

Top Sells

Rank Stock Value
1
DT icon
Dynatrace
DT
+$15.4M

Sector Composition

Rank Sector Weight
1 Industrials 1%
2 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
State Street SPDR S&P 500 ETF Trust
SPY
$811B
$298M 99%
+627,563
New +$280M
PCT icon
2
PureCycle Technologies
PCT
$1.44B
$3M 1%
741,891
DT icon
3
Dynatrace
DT
$14.4B
-330,000
Closed -$15.4M

Similar funds

Howard Hughes Medical Institute's Q4 2023 Portfolio in Review

As of Q4 2023, Howard Hughes Medical Institute held 3 positions worth $301M, up 1,439% from $19.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Howard Hughes Medical Institute deployed $264M of net new capital in Q4 2023, opening 1 new position. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 627,563 shares worth $298M.

By sector, the portfolio is most concentrated in Industrials at 1% of assets, down from 21% a quarter earlier, followed by Technology.

On the sell side, the most notable exit was Dynatrace, an estimated $15.4M sold.

  • Howard Hughes Medical Institute's largest Q4 2023 buy was State Street SPDR S&P 500 ETF Trust: 627,563 shares worth $298M.
  • Howard Hughes Medical Institute fully exited Dynatrace in Q4 2023, selling an estimated $15.4M.
  • Howard Hughes Medical Institute's ten largest holdings make up 100% of its $301M portfolio in Q4 2023.
  • Howard Hughes Medical Institute opened 1 new position and closed 1 in Q4 2023.
  • Howard Hughes Medical Institute's portfolio value rose 1,439% quarter-over-quarter to $301M.

Based on Howard Hughes Medical Institute's 13F filing for Q4 2023, filed 14 Feb 2024.